跳至主要内容
临床试验/CTRI/2012/05/002706
CTRI/2012/05/002706已完成未知

PROSPECTIVE OBSERVATIONAL STUDY OF ROTAVIRUS INFECTION IN INFANTS IN PALWAL, HARYANA, INDIA TO PREPARE FOR A PROPOSED ROTAVIRUS VACCINE EFFICACY TRIA

Serum Institute of India Ltd Pune0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • For all participants:
  • 1. Healthy infants as established by medical history and clinical
  • examination before entering into the study.
  • 2. Parental / legal guardian ability and willingness to provide
  • informed consent.
  • 3. Parent / legal guardian who will remain in the area during the
  • study period.
  • Additional criteria for cohort 1:
  • 4. Age: 6-8 weeks at the time of enrollment.
  • Additional criteria for cohort 2:
  • 5. Age: 8-12 months at the time of enrollment.

排除标准

  • 1. Presence of diarrhea or vomiting in the previous 24 hours or on
  • the day of enrolment (temporary exclusion).
  • 2. Presence of high fever on the day of enrolment (temporary
  • exclusion).
  • 3. History of congenital abdominal disorders, intussusception,
  • abdominal surgery or any other congenital disorder.
  • 4. Known or suspected impairment of immunological function based
  • on medical history and physical examination.
  • 5. Subjects who have received rotavirus vaccine.
  • 6. History of chronic diarrhea (defined as diarrhea more than 14
  • 7. Subject parents who will not be available or willing for active
  • weekly follow-up by the study staff.
  • 8. Chronic administration (defined as more than 14 days) of
  • immunosuppressants including corticosteroids since birth. Infants on
  • inhaled or topical steroids may be permitted to participate in the
  • 9. History of any neurologic disorders or seizures.
  • 10. Any medical condition in the parents / legal guardian / infants
  • that, in the judgment of the investigator, would interfere with or
  • serves as a contraindication to protocol adherence or a participantâ??s
  • ability to give informed consent.

研究者

发起方
Serum Institute of India Ltd Pune

相似试验